Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study

Novel oxazolxanthone derivatives as a new type of α-glucosidase inhibitor: synthesis, activities, inhibitory modes and synergetic effect

(2018) Sen-Miao Ding et al.   BIOORGANIC & MEDICINAL CHEMISTRY

New 6-amino-pyrido[2,3- d ]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α -glucosidase inhibition, molecular modeling and kinetic study

(2018) Mehdi Adib et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study

(2018) Rashad Al-Salahi et al.   Future Medicinal Chemistry

Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors

(2017) Guangcheng Wang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

α-Glucosidase inhibitory effect of resveratrol and piceatannol

(2017) Albert J. Zhang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives

(2017) Hatem A. Abuelizz et al.   MOLECULES

Synthesis, α-glucosidase inhibition and molecular docking studies of novel thiazolidine-2,4-dione or rhodanine derivatives

(2017) Guang-cheng Wang et al.   MedChemComm

Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors

(2016) Guangcheng Wang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α -glucosidase inhibitory activity, and molecular modeling studies

(2016) Uzma Salar et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat

(2016) Himadri Kalita et al.   Frontiers in Pharmacology

Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors

(2015) Santanu Hati et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Synthesis of novel flavone hydrazones: In-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies

(2015) Syahrul Imran et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives

(2014) Qi-Qin Wang et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Biological effects of a new set 1,2,4-triazolo[1,5-a]quinazolines on heart rate and blood pressure

(2014) Rashad Al-Salahi et al.   Chemistry Central Journal

Design, synthesis, and biological evaluation of quinazoline derivatives as α-glucosidase inhibitors

(2014) Venkateshwarlu Gurram et al.   MEDICINAL CHEMISTRY RESEARCH

Global estimates of diabetes prevalence for 2013 and projections for 2035

(2013) L. Guariguata et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Development of α-glucosidase inhibitors by room temperature C–C cross couplings of quinazolinones

(2013) Ramesh Garlapati et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Synthesis of Novel 2-Methylsulfanyl-4H-[1,2,4]triazolo[1,5-a]quinazolin-5-one and Derivatives

(2011) Rashad Al-Salahi et al.   SYNTHETIC COMMUNICATIONS

Natural Products as α-Amylase and α-Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update

(2010) R. Tundis et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Synthesis and Reactivity of [1,2,4]Triazolo-annelated Quinazolines

(2010) Rashad A. Al-Salahi   MOLECULES

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

(2009) Garrett M. Morris et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY